Saving the Lives of People with Blood Cancer
by
Jonathan in the Patient Services team discusses recent research into the use of cell therapies to treat Graft versus Host Disease (GvHD), which is a common side effect of stem cell transplant. He also looks at the implications this may have for patients whose symptoms have not responded to standard treatments. Graft vs Host…
by
Emilie’s husband had his stem cell transplant in 2014 for blast crisis chronic myeloid leukaemia (CML). She spoke to Caroline in Patient Services about caring for her husband while dealing with anxiety, and feelings of guilt about her son being raised by other family members. Can you tell me about when Ben became unwell? It…
An Anthony Nolan presentation moved Farida Dedes to sign up to the stem cell register. But it was a shock in 2016 when she found out she desperately needed a stem cell transplant herself. I was diagnosed with leukaemia soon after I turned 20.I was in my second year of university at the time and…
In recent years, the development of smart phones that are continuously connected to the internet has revolutionised virtually every aspect of our lives. We are now starting to see this technology being used to improve patient health care as well; including how patients document their symptoms and feed back to clinicians. Although improved communication between…
Ashling was diagnosed with late-stage acute myeloid leukaemia when she was just 25 years old. After undergoing treatment, including chemotherapy, she went on to have a stem cell transplant in 2012. In this blog she talks to the Patient Services team about her recovery and how she was able to self-manage her situation. When you…
Graft vs Host Disease (GvHD) is a common complication for many patients during their recovery after a stem cell transplant. It’s caused by small differences between the new immune system and the patient’s other cells. This means the growing immune system may harm some of these cells because it sees them as ‘different’. It can…
